BTIG downgraded Hologic (NASDAQ: HOLX) from Buy to Neutral. Analyst Sean Lavin said strong results are priced in and he ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE